Clinical trial Recruiting at 1 site Observational Ages 10 to 90

Photon-counting CT vs conventional CT for carotid plaque in people with carotid artery stenosis

Official title: Prospective Comparison of Photon-Counting Detector CT and Conventional Energy-Integrating Detector CT for Carotid Atherosclerotic Plaque Assessment in Patients With Carotid Artery Stenosis

Run by Chinese PLA General Hospital · NCT07762664 · Data updated 2026-11-12

This study tests whether photon-counting CT gives clearer, more detailed pictures of carotid plaques compared with standard CT in patients with carotid artery stenosis to help characterize plaque features.

More Carotid Artery Stenosis trials

Quick facts

Study typeObservational
Ages10 Years to 90 Years
SexAll
Enrollment100 (estimated)
SponsorChinese PLA General Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedJanuary 7, 2026
Main results expectedJanuary 7, 2029
Study endsJanuary 7, 2029
Registry record updatedAugust 20, 2026
Trial IDNCT07762664 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 and older with carotid atherosclerotic plaque or carotid artery stenosis who are scheduled for carotid procedures or preprocedural CTA and can provide consent.

Probably not a fit

Patients whose plaques are not better visualized by photon-counting CT or whose clinical care would not change based on imaging results may not experience direct benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective observational study comparing photon-counting detector CT angiography (PCD-CTA) with conventional energy-integrating detector CTA (EID-CTA) for assessing carotid atherosclerotic plaques in patients with carotid artery stenosis. Researchers will analyze differences in visualization, plaque morphology, plaque burden, components, calcification artifacts, and the degree of stenosis, alongside objective and subjective image quality. The goal is to determine if PCD-CTA’s higher spatial resolution and spectral imaging offer advantages over conventional CT for carotid disease characterization. No interventions are randomized or assigned; imaging findings from both methods will be contrasted to identify potential benefits.

Why it matters

Potential benefit: If successful, the study could lead to more accurate plaque characterization and improved planning for carotid interventions using photon-counting CT.

How similar studies have gone: Prior research in photon-counting CT suggests improved image quality and material differentiation, but its specific use for carotid plaque characterization is still being explored.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older.
* Patients with carotid atherosclerotic plaque or carotid artery stenosis.
* Patients scheduled to undergo carotid artery stenting.
* Patients undergoing preprocedural carotid CTA examination.
* Ability to provide written informed consent.

Exclusion Criteria:

* Known allergy to iodinated contrast material.
* Severe renal insufficiency or other contraindications to contrast-enhanced CT.
* Pregnancy or suspected pregnancy.
* Severe motion or other artifacts resulting in nondiagnostic image quality.
* Incomplete clinical or imaging data.

Where it's running

  • Chinese PLA General Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.